Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue

International Journal of Urology

Volumn 14, Issue 8, 2007, Pages 754-759

  Fujimoto, Kiyohide ^a   Matsumura, Yoshiaki ^a   Tani, Yoshihiro ^a   Ozono, Seiichiro ^b   Hirao, Yoshihiko ^a   Okajima, Eigoro ^c  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Takanohara Central Hospital   (Japan)

Author keywords

Bladder cancer; Pyrimidine nucleoside phosphorylase; Tissue level

Indexed keywords

N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE; PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE LEVEL;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BUTYLHYDROXYBUTYLNITROSAMINE; CARCINOGENS; CARCINOMA, PAPILLARY; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C3H; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PENTOSYLTRANSFERASES; RATS; RATS, INBRED F344; RISK FACTORS; SPECIES SPECIFICITY; THYMIDINE PHOSPHORYLASE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 34547642692     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01801.x     Document Type: Article

References (28)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? N. Engl. J. Med. 1990 285 : 82 6.
2. Weidner N, Folkman J, Pozza F et al. Tumor angiogenesis. a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 1992 84 : 1875 87.
3. Horak ER, Leek R, Klenk N et al. Angiogenesis assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet 1992 340 : 1120 4.
4. Srivasta A, Laidler P, Davies R, Horgan K, Hugehes LE. The prognostic significance of tumour vascularity in intermediate-thickness (0.76-4mm thick) skin melanoma. Am. J. Pathol. 1988 133 : 419 23.
5. Vesalainen S, Lipponen P, Talja M, Alhara E, Syrjanen K. Tumour vascularity and basement membrane structure as prognostic factor in T12M0 prostatic adenocarcinoma. Anticancer Res. 1998 14 : 709 14.
6. Wakui S, Furusato M, Itoh T. Tumour angiogenesis in prostatic adenocarcinoma. Anticancer Res. 1994 14 : 709 14.
7. O'Brien T, Cranston D, Fuggle S et al. Different angiogenic pathways characterize non-muscle invasive and invasive bladder cancer. Cancer Res. 1995 55 : 510 13.
8. O'Brien TS, Fox SB, Dickinson AJ et al. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res. 1996 56 : 4799 804.
9. Kubota Y, Miura T, Moriyama M et al. Thymidine phosphorylase activity in human bladder cancer difference between non-muscle invasive and invasive cancer. Clin. Cancer Res. 1997 3 : 973 6.
10. Mizutani Y, Okada Y, Yoshida O. Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 1997 79 : 1190 4.
11. Tanaka T, Yoshiki T, Arai Y et al. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human bladder cancer. Jpn J. Cancer Res. 1999 90 : 1344 50.
12. Arima J, Imazono Y, Takebayashi Y et al. Expression of thymidine phosphorylase as an indicator of poor prognosis for patients with transitional cell carcinoma of the bladder. Cancer 2000 88 : 1131 8.
13. Li N, Kanda K, Fukumori T et al. Expression of vascular endothelial growth factor isoforms and platelet-derived endothelial cell growth factor in bladder cancer. Urol. Oncol. 2001 6 : 10 15.
14. Li S, Nomata K, Sawase Knogushi M, Kanda S, Kanetake H. Prognostic significance of platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in stage pT1, G3 bladder cancer. Int. J. Urol. 2001 8 : 478 82.
15. Ishikawa F, Miyazono K, Hellman U et al. Identification of angiogenic activity and the cloning and expression of the platelet-derived endothelial cell growth factor. Nature 1989 338 : 557 62.
16. Takebayashi Y, Akiyama S, Akiba S et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J. Natl. Cancer Inst. 1996 88 : 110 17.
17. Takebayashi Y, Natsugoe S, Baba M et al. Thymidine phosphorylase in human esophageal squamous cell carcinoma. Cancer 1999 85 : 282 9.
18. Takao S, Takebayashi Y, Xiangming C et al. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin. Cancer Res. 1998 4 : 1619 24.
19. Dickinson A, Fox S, Persad R, Hollyer J, Sibley G, Harris AL. Quantitation of angiogenesis is an independent predictor of prognosis in invasive bladder cancer. Br. J. Urol. 1995 74 : 762 6.
20. Druckrey H, Preussmann R, Ivankovic S, Schmidt CH, Mennel HD, Stahl KW. Selektive Erzeugung von Blasenkrebs an Rtten durch Dibutyl-und N-butyl-N-Butanol(4)-nitrosamin. Z. Krebsforsch 1964 66 : 280 90.
21. Ohtani M, Kakizoe T, Nishio Y et al. Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl) nitrosamine. Cancer Res. 1986 46 : 2001 4.
22. Lowry OH, Rosebroough NJ, Farr AC, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193 : 265 75.
23. Eda H, Fujimoto K, Watanabe S et al. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol. 1993 32 : 333 8.
24. Moghaddam A, Zhang HT, Fan TP et al. Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc. Natl. Acad. Sci. 1995 92 : 998 1002.
25. Brown NS, Jones A, Fujiyama C, Harris AL, Bicknell R. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 2000 60 : 6298 302.
26. Jones A, Fujiyama C, Turner K et al. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion. J. Urol. 2002 167 : 1482 6.
27. Schwartz EL, Hoffman M, O'Connor CJ, Wadler S. Stimulation of 5-fluorouracil metabolic activation by interferon-Áin human colon carcinoma cells. Biochem. Biophys. Res. Commun. 1992 182 : 1232 9.
28. Tavaearai HT, Laurent PL, Suardet L, Eliason JF, Givel N, Odartchenko N. Interactions of interferon-α2a with 5-deoxy-5-fluorouridine in colorectal cancer cells in vitro. Eur. J. Cancer 1992 28 : 368 72.